NCT02245464View on ClinicalTrials.gov

Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension

CompletedOBSERVATIONAL
Enrollment

13,066

Participants

Timeline

Start Date

November 30, 2000

Primary Completion Date

November 30, 2006

Conditions
Hypertension
Interventions
DRUG

Telmisartan

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY